FDA Drug recall D-1317-2014
Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Suj…
- FDA Drug
- Class II
- completed
- Published 2014-05-21
On 2014-05-21 the FDA classified a Class II recall of Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Suj… by Flawless Beauty, citing marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1317-2014 |
| Classification | Class II |
| Status | completed |
| Initiated | 2014-04-29 |
| Published | 2014-05-21 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Flawless Beauty |
| Distribution | US |
Product
Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576
Reason
Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.
Identifiers
| upc | 4973430081576 |
|---|---|
| code_info | Lot #: UB302, Exp 05/12/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1317-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.